Who owns ORAMED PHARMACEUTICALS INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of ORMP from SEC Form 13F filings across 69 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 69 institutions disclosed 8.8M shares of ORAMED PHARMACEUTICALS INC. worth $41.7M — about 21.4% of shares outstanding; the largest disclosed holder is MERCER GLOBAL ADVISORS INC /ADV. Source: SEC Form 13F filings, parsed by EvidInvest.
69
13F holders
$41.7M
value, 2026 filers
21.4%
of shares outstanding (8.8M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ORMP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MERCER GLOBAL ADVISORS INC /ADV | 1.9M | $9.2M | 0.0% | 4.7% | 0.0% |
| 2 | BlackRock, Inc. | 1.6M | $7.7M | 0.0% | 3.9% | +1644.3% |
| 3 | Murchinson Ltd. | 1.3M | $6.2M | 0.9% | 3.1% | -1.9% |
| 4 | BOOTHBAY FUND MANAGEMENT, LLC | 578,638 | $2.8M | 0.0% | 1.4% | -3.7% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 500,690 | $2.4M | 0.0% | 1.2% | +1962.0% |
| 6 | GOLDMAN SACHS GROUP INCNEW | 253,293 | $1.2M | 0.0% | 0.6% | new |
| 7 | Rathbones Group PLC | 233,018 | $1.1M | 0.0% | 0.6% | 0.0% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 229,882 | $1.1M | 0.0% | 0.6% | new |
| 9 | NORTHERN TRUST CORPNEW | 184,920 | $889,465 | 0.0% | 0.5% | new |
| 10 | RITHOLTZ WEALTH MANAGEMENT | 168,694 | $811,418 | 0.0% | 0.4% | +8.5% |
| 11 | WELLS FARGO & COMPANY/MN | 166,000 | $798,458 | 0.0% | 0.4% | +5.3% |
| 12 | BANK OF AMERICA CORP /DE/ | 150,694 | $724,838 | 0.0% | 0.4% | +3.1% |
| 13 | STRS OHIONEW | 133,800 | $643,578 | 0.0% | 0.3% | new |
| 14 | JANE STREET GROUP, LLC | 113,349 | $545,209 | 0.0% | 0.3% | +115.7% |
| 15 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 102,962 | $495,247 | 0.0% | 0.3% | -11.5% |
| 16 | MARSHALL WACE, LLP | 101,953 | $490,393 | 0.0% | 0.2% | -60.7% |
| 17 | HRT FINANCIAL LP | 97,582 | $469 | 0.0% | 0.2% | +254.9% |
| 18 | Sixth Street Partners Management Company, L.P.NEW | 83,634 | $402,280 | 0.1% | 0.2% | new |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 83,634 | $402,280 | 0.0% | 0.2% | new |
| 20 | Bank of New York Mellon CorpNEW | 79,255 | $381,217 | 0.0% | 0.2% | new |
| 21 | UBS Group AG | 67,671 | $325,498 | 0.0% | 0.2% | +480.0% |
| 22 | AMERICAN CENTURY COMPANIES INC | 59,775 | $287,518 | 0.0% | 0.1% | +85.0% |
| 23 | Nuveen, LLCNEW | 46,404 | $223,203 | 0.0% | 0.1% | new |
| 24 | MORGAN STANLEY | 43,357 | $208,547 | 0.0% | 0.1% | +208.5% |
| 25 | CITADEL ADVISORS LLC | 41,565 | $199,927 | 0.0% | 0.1% | -57.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.